This article describes our methods for structured continuous glucose monitoring (CGM)-guided insulin dosing in pump-treated type 1 diabetes. Some of the methods have been reported and some are based on clinical experience. It is expected that this guide will help those involved in the care of such patients and who have experience with CGM to achieve better glucose control in their patients. More research needs to be done on insulin dosing and we hope that this article will also encourage others to pursue this field. This is a guide and, as such, is not meant to replace clinical judgment. Also, these dosing approaches apply only to those patients on pump therapy. They do not necessarily carry over to those patients treated with basal analog insulin.
BlissM. The discovery of insulin. Chicago (IL): The University of Chicago Press; 1981. p. 112–3.
2.
DavidsonPCHebblewhiteHRSteedRDBodeBW. Analysis of guidelines for basal-bolus insulin dosing: Basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract.2008;14 (9): 1095–101.
3.
BodeBW. Therapy for diabetes mellitus and related disorder. In: LebovitzH, editor. Insulin pump therapy. 4th ed.Alexandria (VA): American Diabetes Association; 2004. p. 224–31.
4.
WolpertH, editor. Smart pumping for people with diabetes.Alexandria (VA): American Diabetes Association; 2002.
5.
BolandEMonsodTDeluciaMBrandtCAFernandoSTaborlaneW V. Limitations of conventional methods of self-monitoring of blood glucose: Lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care.2001;24 (11): 1858–62.
6.
KaufmanFRGibsonLCHalvorsonMCarpenterSFisherLKPitukcheewanontP. A pilot study of the continuous glucose monitoring system: Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care.2001;24 (12): 2030–4.
7.
KingABArmstrongDU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing. J Diabetes Sci Technol.2007;1 (1): 36–41.
8.
KingABArmstrongDU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Bolus dosing. J Diabetes Sci Technol.2007;1 (1): 42–6.
9.
KingAB. How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring. Endocr Pract.2010;16 (3): 428–32.
10.
MobergEKollindMLinsPEAdamsonU. Day-to-day variation of insulin sensitivity in patients with type 1 diabetes: Role of gender and menstrual cycle. Diabet Med.1995;12 (3): 224–8.
11.
KingA. Stability of insulin dose settings. Diabetes.2007;56 (Suppl 1): A548.
12.
WolfeGKingAB. Stability of insulin dosing parameters over multiple years (589-P). Diabetes.2009;58 (Suppl 1): A159.
13.
BeckerRHFrickADNosekLHeinemannLRaveK. Dose-response relationship of insulin glulisine in subjects with type 1 diabetes. Diabetes Care.2007;30 (10): 2506–7.
14.
Van CauterEPolonskyKSScheenAJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev.1997;18 (5): 716–38.
15.
American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care.2010;33 (Suppl 1): S11–61.
16.
ClarkDKingAB. Basal glucose testing: A carbohydrate free meal does not equal meal omission (2111-PO). Diabetes.2010;59 (Suppl 1): A554.
17.
RasmussenO. Dose-dependency of the glycemic response to starch-rich meals in insulin-dependent diabetic subjects: Studies at constant insulinemia. Metabolism.1993;42 (6): 710–3.
18.
HalfonPBelkhadirJSlamaG. Correlation between amounts of carbohydrate in mixed meals and insulin delivery by artificial pancreas in seven IDDM subjects. Diabetes Care.1989;12 (6): 427–9.
19.
Rabasa-LhoretRGaronJLangelierHPoissonDChiassonJL. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen. Diabetes Care.1999;22 (5): 667–73.
20.
FranzMJ. The glycemic index: Not the most effective nutrition therapy intervention. Diabetes Care.2003;26 (8): 2466–8.
21.
PetersALDavidsonMB. Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. Am J Clin Nutr.1993;58 (4): 555–60.
22.
PańkowskaE. An analysis of the “bolus guide,” a new insulin bolus dosing support tool based on selection of carbohydrate ranges. J Diabetes Sci Technol.2010;4 (4): 903–5.
23.
BishopFKMaahsDMSpiegelGOwenDKlingensmithGJBortsovAThomasJMayer-DavisEJ. The carbohydrate counting in adolescents with type 1 diabetes (CCAT) study. Diabetes Spectr.2009;22 (1): 56–62.
24.
ArmstrongDUKingAB. Assessment of patient error in meal carbohydrate content estimation (2432-PO). Diabetes.2007;56 (Suppl 1): A616.
25.
HeinemannLNosekLKapitzaCSchweitzerMAKrinelkeL. Changes in basal insulin infusion: Time until a change in metabolic effect is induced in patients with type 1 diabetes. Diabetes Care.2009;32 (8): 1437–9.
26.
HeinemannL. Insulin pump therapy: What is the evidence for using different types of boluses for coverage of prandial insulin requirements?. J Diabetes Sci Technol.2009;3 (6): 1490–500.
27.
KingAB. Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used. Endocrin Pract.2009;15 (3): 229–33.
28.
KingAB. Comparison of the post-meal glucose response to different insulin bolus waveforms in insulin pump- and pre-meal pramlintide-treated type 1 diabetes patients. Diabetes Technol Therap.2010;12 (2): 105–8.
